Metered Dose Inhaler Clinical Trials
- Bronchodilatation Effects of a Small Volume Spacer Used With a Metered-Dose Inhaler
ClinicalTrials.gov Identifier: NCT00465413 - Completed
Asthma
- Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
ClinicalTrials.gov Identifier: NCT00162487 - Recruiting
Hyperkalemia; Chronic Renal Failure
- Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
ClinicalTrials.gov Identifier: NCT00404261 - Completed
Asthma; COPD
- Efficacy Study of Single-Dose Levalbuterol Tartrate Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) Versus Placebo in Prevention of Exercise-Induced Bronchospasm (EIB) in Subjects 18 Years of Age and Older With Exercise-Induced Bronchospasm
ClinicalTrials.gov Identifier: NCT00268723 - Completed
Exercise-Induced Bronchospasm
- A Randomised Open Label, Six Way, Cross-Over Scintigraphic Evaluation of the Effect of Inspiratory Flow Rate on Lung and Oropharyngeal Deposition with the Respimat® Inhaler Vs. a Metered Dose Inhaler (HFA-MDI) Using Berodual® in Patients with Ch
ClinicalTrials.gov Identifier: NCT00153075 - Completed
Pulmonary Disease, Chronic Obstructive; Asthma
- Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
ClinicalTrials.gov Identifier: NCT00556673 - Recruiting
Asthma
- A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov Identifier: NCT00239434 - Completed
Pulmonary Disease, Chronic Obstructive
- Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
ClinicalTrials.gov Identifier: NCT00096616 - Completed
Asthma
- Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
ClinicalTrials.gov Identifier: NCT00530062 - Recruiting
Asthma
- Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children
ClinicalTrials.gov Identifier: NCT00094016 - Completed
Asthma
- A Study to Evaluate a Fixed dose of CellCept Compared to Adjusted Dose of CellCept in Patients following a Single Organ Kidney Transplant in Combination with Full Dose and Reduced Dose of Calcineurin Inhibitors
ClinicalTrials.gov Identifier: NCT00087581 - Active, not recruiting
renal transplant
- Chronic-Dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics
ClinicalTrials.gov Identifier: NCT00308685 - Completed
Asthma
- Compare How Effective Standard Dose Proton Pump Inhibitor (PPI) and Low Dose Tricyclic Antidepressant and Double Dose PPI to Standard Dose PPI and Placebo
ClinicalTrials.gov Identifier: NCT00539240 - Recruiting
Gastroesophageal Reflux Disease
- A Two-Week Study Assessing the Onset of Effect Questionnaire Administered Pre-Dose Versus Post-Dose in Adult Subjects
ClinicalTrials.gov Identifier: NCT00449501 - Active, not recruiting
Asthma
- DESOLO – SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
ClinicalTrials.gov Identifier: NCT00252863 - Active, not recruiting
Asthma
- Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00394199 - Active, not recruiting
Asthma
- Extension Study of Enteric-Coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
ClinicalTrials.gov Identifier: NCT00238940 - Active, not recruiting
Renal Transplantation
- MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
ClinicalTrials.gov Identifier: NCT00242411 - Active, not recruiting
Asthma
- New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00394121 - Active, not recruiting
Asthma
- High Dose CVVHDF Compared to Standard Dose CVVHDF
ClinicalTrials.gov Identifier: NCT00561431 - Active, not recruiting
Acute Renal Failure
- NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler
ClinicalTrials.gov Identifier: NCT00557297 - Recruiting
Asthma
- A Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Study to Assess the Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara Smallpox Vaccine
ClinicalTrials.gov Identifier: NCT00466245 - Active, not recruiting
Smallpox
- Title: A Phase 2 (a), Dose-Blinded, Block-Randomized, Dose and Schedule Selection Study to Evaluate the Immunogenicity and Safety of the Recombinant Plague Vaccine rF1V in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00332956 - Active, not recruiting
Healthy Volunteers
- Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
ClinicalTrials.gov Identifier: NCT00476099 - Recruiting
Chronic Obstructive Pulmonary Disease
- A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
ClinicalTrials.gov Identifier: NCT00271466 - Active, not recruiting
Chronic Pain
- Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
ClinicalTrials.gov Identifier: NCT00403637 - Completed
Asthma
- Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
Asthma
- An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
ClinicalTrials.gov Identifier: NCT00528996 - Recruiting
Pulmonary Disease, Chronic Obstructive
- Comparative effectiveness of a breath-operated albuterol inhaler in asthma patients with poor inhaler technique
ClinicalTrials.gov Identifier: NCT00054964 - Completed
Asthma
- High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
Idiopathic Thrombocytopenic Purpura
- Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
ClinicalTrials.gov Identifier: NCT00549510 - Recruiting
Hypertension
- Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i’s vs. Single Maximal Dose PDE5i
ClinicalTrials.gov Identifier: NCT00498680 - Recruiting
Impotence
- Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
ClinicalTrials.gov Identifier: NCT00385593 - Recruiting
Asthma, Bronchial
- Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
ClinicalTrials.gov Identifier: NCT00583102 - Recruiting
Acute Myeloid Leukemia
- A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557
ClinicalTrials.gov Identifier: NCT00578682 - Recruiting
Healthy
- Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
ClinicalTrials.gov Identifier: NCT00393991 - Recruiting
Asthma
- A Randomized, Multiple-Dose, Double-Blind, Placebo- and Active Controlled, Parallel Group Efficacy and Safety Study to Determine the Optimum Dose of BEA 2180 BR Delivered by the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov Identifier: NCT00122434 - Completed
Pulmonary Disease, Chronic Obstructive
- Determination of Fraction Size Equivalent Dose (FED) Dose Levels for Intracranial Conformal Avoidance Radiotherapy
ClinicalTrials.gov Identifier: NCT00214175 - Recruiting
Low Grade Gliomas and Benign CNS Lesions
- Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
ClinicalTrials.gov Identifier: NCT00524641 - Recruiting
Asthma
- Evaluation of Pre-Dose and Post-Dose Anti-Factor Xa Levels With Enoxaparin Use During Pregnancy
ClinicalTrials.gov Identifier: NCT00319176 - Recruiting
Pregnancy
- High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
ClinicalTrials.gov Identifier: NCT00474006 - Recruiting
Acute Myelogenous Leukemia
- Immunogenicity and Safety of a 1-Dose Regimen of a Zoster Vaccine Versus Different 2-Dose Regimens in Subjects ≥ 70 Years
ClinicalTrials.gov Identifier: NCT00561080 - Recruiting
Prevention of : Herpes-Zoster
- How Side Effects of Avonex Are Affected by Gradaully Increasing to Full Dose vs Starting at Full Dose
ClinicalTrials.gov Identifier: NCT00574041 - Recruiting
Relapsing Remitting Multiple Sclerosis
- STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
ClinicalTrials.gov Identifier: NCT00252824 - Recruiting
Asthma
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00381680 - Recruiting
Leukemia
- Bone Response to Soy Isoflavones in Women
ClinicalTrials.gov Identifier: NCT00043745 - Active, not recruiting
Osteopenia; Osteoporosis
- Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids
ClinicalTrials.gov Identifier: NCT00239031 - Active, not recruiting
De Novo Renal Transplantation
- New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
ClinicalTrials.gov Identifier: NCT00393952 - Recruiting
Asthma
- Phase I, Open-Label, Multi-Center, SIngle-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic Study of GC1008 in Patients with IPF
ClinicalTrials.gov Identifier: NCT00125385 - Active, not recruiting
Idiopathic Pulmonary Fibrosis; IPF
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
ClinicalTrials.gov Identifier: NCT00005778 - Active, not recruiting
Lupus Erythematosus, Systemic
- Randomized, Open-Label, Comparative Safety and Efficacy Study of Tipranavir Boosted with Low-Dose Ritonavir (TPV/RTV) Versus Genotypically-Defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-Experienced Patients (RESIST 2)
ClinicalTrials.gov Identifier: NCT00144170 - Active, not recruiting
HIV Infections
- UARK 2003-41: A Study of High-Dose Density Therapy in Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00113932 - Active, not recruiting
Multiple Myeloma
- Tramadol iv. : Influence of Dose and Dose Intervals on Therapeutic Accuracy and Side Effects When Used for Postoperative Pain Relief in Ambulatory Surgery
ClinicalTrials.gov Identifier: NCT00333346 - Recruiting
Ambulatory Surgery
- Single-Dose, Dose-Escalation Study of Safety, PK, & Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00541983 - Recruiting
Type 2 Diabetes
- Dose and Dose Interval Study of Myozyme
ClinicalTrials.gov Identifier: NCT00483379 - Recruiting
Pompe Disease; Glycogen Storage Disease Type II (GSD-II); Glucogenesis 2; Acid Maltase Deficiency
- Carotid Plaque Regression With High Dose Atorvastatin Versus Conventional Dose Simvastatin Using High Field MRI
ClinicalTrials.gov Identifier: NCT00388843 - Recruiting
Carotid Atherosclerosis
- Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
Diabetes Mellitus
- High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00313547 - Recruiting
Hypertension
- Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults
ClinicalTrials.gov Identifier: NCT00548483 - Recruiting
Airway Obstruction
- Dose-Escalating Multiple Dose Study of PD 0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00550355 - Recruiting
Arthritis, Rheumatoid
- Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00477971 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- High-Dose Total-Body Irradiation, Cyclophosphamide, Antithymocyte Globulin, and Autologous Stem Cell Transplant or High-Dose Cyclophosphamide in Treating Patients With Severe Systemic Sclerosis
ClinicalTrials.gov Identifier: NCT00545038 - Recruiting
Precancerous/Nonmalignant Condition
- A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
ClinicalTrials.gov Identifier: NCT00000815 - Active, not recruiting
HIV Infections; Measles
- Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00521261 - Recruiting
Lymphoma
- Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
ClinicalTrials.gov Identifier: NCT00473616 - Recruiting
Advanced Solid Tumors; Cancer; Advanced Solid Malignancies
- Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy
ClinicalTrials.gov Identifier: NCT00205764 - Recruiting
Multiple Myeloma
- High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00533949 - Recruiting
Lung Cancer; Radiation Toxicity
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for
ClinicalTrials.gov Identifier: NCT00515138 - Recruiting
B-Cell Non-Hodgkin's Lymphoma
- Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects
ClinicalTrials.gov Identifier: NCT00538057 - Not yet recruiting
Healthy Volunteers
- Study Comparing Standard Dose and High-Dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov Identifier: NCT00171899 - Recruiting
Chronic Myelogenous Leukemia
- High-Dose Vs. Standard-Dose Oseltamivir (Tamiflu) to Treat Severe Influenza and Avian Influenza
ClinicalTrials.gov Identifier: NCT00298233 - Recruiting
Influenza in Birds; Severe Influenza
- A Phase II Study Comparing Low- and High-Dose CAMPATH and High-Dose Rebif in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00050778 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
- Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
ClinicalTrials.gov Identifier: NCT00527150 - Not yet recruiting
Smoking Cessation
- Evaluation of the Combined Use of L-Arginine and Angiogenic Factors in Patients Undergoing Surgery for Severe, Diffuse Coronary Artery Disease
ClinicalTrials.gov Identifier: NCT00134433 - Active, not recruiting
Coronary Artery Disease, Diffuse; Coronary Artery Disease, Deemed Inoperable
- Dose-Comparison Study.
ClinicalTrials.gov Identifier: NCT00185380 - Active, not recruiting
Contraception
- Enteric-Coated Mycophenolate Sodium (EC-MPS) With Reduced-Dose Tacrolimus Versus EC-MPS With Standard-Dose Tacrolimus in Stable Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00284934 - Recruiting
Kidney Diseases
- High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00082797 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- H5 Booster After a Two Dose Schedule
ClinicalTrials.gov Identifier: NCT00240968 - Active, not recruiting
Influenza
- Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov Identifier: NCT00396604 - Completed
Pulmonary Disease, Chronic Obstructive; COPD; Lung Diseases, Obstructive
- Higher Dose Intradermal H5 Vaccine
ClinicalTrials.gov Identifier: NCT00439335 - Active, not recruiting
Influenza
- Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
ClinicalTrials.gov Identifier: NCT00226408 - Recruiting
Adjuvant; Stage III Malignant Melanoma; Interferon Alpha; Therapy
- Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) with Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
ClinicalTrials.gov Identifier: NCT00038649 - Active, not recruiting
Myelogenous Leukemia, Chronic, Chronic Phase
- Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00499018 - Recruiting
Diffuse Large B-Cell Lymphoma; IPI≥2
- Pneumococcal Adult-Dose Ranging Immunization Study
ClinicalTrials.gov Identifier: NCT00169234 - Active, not recruiting
Pneumonia
- MK0859 Dose-Ranging Study
ClinicalTrials.gov Identifier: NCT00325455 - Active, not recruiting
Hypercholesterolemia; Mixed Hyperlipemia
- The Effect of High Dose Vitamin C in Burn Patients
ClinicalTrials.gov Identifier: NCT00350077 - Active, not recruiting
Burns
- High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
ClinicalTrials.gov Identifier: NCT00080977 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Effect of Albendazole Dose on Clearance of Filarial Worms
ClinicalTrials.gov Identifier: NCT00339417 - Active, not recruiting
Lymphatic Filariasis
- High Dose Chemotherapy Followed By PBSC Rescue for HD
ClinicalTrials.gov Identifier: NCT00186251 - Active, not recruiting
Hodgkin Disease
- Effect of Food Upon Pharmacokinetics of Single Oral Dose of AZD2171
ClinicalTrials.gov Identifier: NCT00306891 - Active, not recruiting
Cancer
- A Dose-Response Study With Strontium Malonate in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00409032 - Active, not recruiting
Osteoporosis
- A/H5N1 Dose Ranging Study With Adjuvant Patch
ClinicalTrials.gov Identifier: NCT00532792 - Active, not recruiting
Pandemic Influenza
- Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00006265 - Active, not recruiting
recurrent adult acute myeloid leukemia
- Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
ClinicalTrials.gov Identifier: NCT00327262 - Recruiting
Chronic Myeloid Leukemia
- Efficacy and Tolerability of Full Dose Enteric-Coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients
ClinicalTrials.gov Identifier: NCT00434590 - Not yet recruiting
Kidney Transplantation
- High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
ClinicalTrials.gov Identifier: NCT00002948 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
ClinicalTrials.gov Identifier: NCT00060255 - Active, not recruiting
Cancer
- Dose-Escalating Safety Study in Subjects on Stable Statin Therapy
ClinicalTrials.gov Identifier: NCT00231569 - Active, not recruiting
Hypercholesterolemia
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
